Disease Info Card

Mucopolysaccharidosis Vi

Information about Mucopolysaccharidosis Vi: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mucopolysaccharidosis Vi

Most recent studies have shown that Mucopolysaccharidosis Vi shares some biological mechanisms with cat-diseases, compression-of-spinal-cord, corneal-diseases, deficiency-of-arylsulfatase, dwarfism, dysplasia, inborn-errors-of-metabolism, leukodystrophy, leukodystrophy-metachromatic, lysosomal-storage-diseases, mucolipidoses, mucopolysaccharidoses, mucopolysaccharidosis-i, mucopolysaccharidosis-ii, mucopolysaccharidosis-iii, mucopolysaccharidosis-iv, nervousness, pfaundler-hurler-syndrome, stenosis, storage-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mucopolysaccharidosis Vi, and have been seen in publications frequently: Bone Development, Bone Maturation, Cardiac Conduction, Cell Death, Endochondral Ossification, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Ossification, Pathogenesis, Pigmentation, Protein Maturation, Proteolysis, Reverse Transcription, Secretion, Sulfate Transport, Translation, Transport

Quite a number of genes have been found to play important roles in Mucopolysaccharidosis Vi, such as ALAS2, ARSA, ARSB, ARSH, CAT, CRAT, DHDDS, DHPS, ELF3, GALNS, GLB1, GLYAT, GUSB, NLRP5, PRPH2, QPCT, RPE, SLURP1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.